Canadian Sec - Delayed Quote CAD

Entheon Biomedical Corp. (ENBI.CN)

0.1000
0.0000
(0.00%)
At close: May 7 at 10:47:39 AM EDT
Advanced Chart
Loading Chart for ENBI.CN
  • Previous Close 0.1000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.4500
  • Volume 0
  • Avg. Volume 17,038
  • Market Cap (intraday) 1.386M
  • Beta (5Y Monthly) 1.58
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Jul 2, 2025 - Jul 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

entheonbiomedical.com

1

Full Time Employees

November 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Entheon Biomedical Corp.

Recent News: ENBI.CN

View More
View More

Performance Overview: ENBI.CN

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ENBI.CN
45.95%
S&P/TSX Composite index (^GSPTSE)
4.05%

1-Year Return

ENBI.CN
39.39%
S&P/TSX Composite index (^GSPTSE)
15.08%

3-Year Return

ENBI.CN
85.71%
S&P/TSX Composite index (^GSPTSE)
27.45%

5-Year Return

ENBI.CN
97.62%
S&P/TSX Composite index (^GSPTSE)
76.63%

Compare To: ENBI.CN

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

ENBI.CN
Entheon Biomedical Corp.
0.1000
0.00%
Mkt Cap CAD 1.386M
Industry Biotechnology
MOOD.CN
Doseology Sciences Inc.
0.4300
0.00%
Mkt Cap CAD 1.935M
Industry Biotechnology
CYBN.NE
Cybin Inc.
9.13
-1.30%
Mkt Cap CAD 194.495M
Industry Biotechnology

Statistics: ENBI.CN

View More

Valuation Measures

As of 5/13/2025

  • Market Cap

    1.39M

  • Enterprise Value

    860.73k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.77

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -70.93%

  • Return on Equity (ttm)

    -137.90%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -317.92k

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    136.49k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -245.63k

View More

Research Analysis: ENBI.CN

View More
View More

People Also Watch

PSYC.CN Psyched Wellness Ltd.
0.0200
0.00%
 
CYBN.NE Cybin Inc.
9.13
-1.30%
 
RVV.CN Revive Therapeutics Ltd.
0.0250
-16.67%
 
PHRM.CN PharmaTher Holdings Ltd.
0.2300
+4.55%
 
MYCO.CN Mydecine Innovations Group Inc.
0.0050
-50.00%
 
TRIP.CN Red Light Holland Corp.
0.0300
0.00%
 
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%
 
ENTBF Entheon Biomedical Corp.
0.0670
0.00%
 
AION.CN Aion Therapeutic Inc.
0.0100
+100.00%
 
BETR.CN BetterLife Pharma Inc.
0.0900
+5.88%
 
EHVVF EHAVE, Inc.
0.0006
-40.00%
 
VST.CN Victory Square Technologies Inc.
0.1950
-7.14%
 
MYCO.NE Mydecine Innovations Group Inc.
0.0100
0.00%
 
DRUG.CN Bright Minds Biosciences Inc.
45.71
-1.66%
 
MYCOF Mydecine Innovations Group Inc.
0.0030
-11.76%
 
OPTI.CN Optimi Health Corp.
0.2250
0.00%